Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -13.06%748.9M | -2.44%812.75M | -17.31%749.68M | 14.67%3.54B | -0.66%943.6M | 6.78%861.44M | 11.64%833.08M | 54.08%906.61M | 20.47%3.09B | 40.15%949.88M |
| Cost of revenue | -16.30%713.5M | -4.70%791.84M | -13.59%706.3M | 10.51%3.33B | -2.60%827.96M | 5.48%852.41M | 10.20%830.85M | 36.27%817.38M | 15.33%3.01B | 31.69%850.02M |
| Gross profit | 291.90%35.4M | 839.16%20.92M | -51.38%43.38M | 172.68%216.14M | 15.80%115.64M | 729.04%9.03M | 128.84%2.23M | 880.33%89.24M | 273.37%79.26M | 209.50%99.86M |
| Operating expense | -47.60%22.89M | 43.20%33.91M | 53.18%25.27M | 5.37%107.23M | -37.54%21.28M | 115.47%43.68M | 427.89%23.68M | -18.70%16.5M | -7.22%101.77M | -31.50%34.07M |
| Selling and administrative expenses | -10.15%22.96M | 14.53%28.04M | -1.96%25.28M | 4.15%104.89M | 5.88%29.92M | 8.01%25.56M | 7.13%24.48M | -0.61%25.78M | -8.82%100.71M | -7.74%28.26M |
| -Selling and marketing expense | 10.23%6.39M | 30.28%6.93M | 28.23%7.33M | -8.67%23.45M | -0.91%6.62M | 14.24%5.79M | -11.86%5.32M | -27.55%5.71M | -35.23%25.68M | -40.86%6.68M |
| -General and administrative expense | -16.12%16.58M | 10.16%21.11M | -10.55%17.95M | 8.54%81.44M | 7.98%23.29M | 6.31%19.76M | 13.95%19.16M | 11.15%20.07M | 5.96%75.03M | 11.63%21.57M |
| Other operating expenses | -95.90%770K | 5,940.98%7.37M | --2M | 97.09%3.65M | ---- | 2,262.39%18.78M | 6,000.00%122K | ---- | 644.58%1.85M | 6,576.60%6.28M |
| Total other operating income | 28.96%846K | 62.20%1.5M | -78.35%2.01M | 65.79%1.32M | 1,785.15%8.63M | -84.32%656K | -94.96%926K | 62.05%9.29M | -21.29%795K | 102.41%458K |
| Operating profit | 136.11%12.51M | 39.44%-12.99M | -75.09%18.12M | 583.98%108.91M | 43.43%94.36M | -59.61%-34.65M | -75.70%-21.45M | 329.29%72.74M | 85.52%-22.5M | 476.34%65.79M |
| Net non-operating interest income (expenses) | 0.32%-9.29M | 0.05%-10.1M | -12.00%-9.65M | 6.49%-37.24M | 26.97%-9.2M | 15.76%-9.32M | -20.49%-10.11M | -10.76%-8.62M | -42.44%-39.83M | -69.56%-12.59M |
| Non-operating interest income | -42.40%811K | -38.18%1.12M | -64.26%990K | -10.89%7.07M | -49.32%1.08M | -33.83%1.41M | -12.96%1.81M | 74.10%2.77M | 97.22%7.93M | 15.95%2.14M |
| Non-operating interest expense | -5.84%10.1M | -5.83%11.22M | -6.55%10.64M | -7.22%44.31M | -30.21%10.28M | -18.68%10.73M | 13.85%11.92M | 21.51%11.39M | 49.32%47.76M | 58.90%14.73M |
| Net investment income | -75.36%1.93M | 17.69%7.85M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | 97.09%-341K | -663.42%-2.28M | 156.06%1.99M | -103.50%-384K | 1,522.57%10.84M | -1,098.98%-11.7M | -104.54%-298K | -87.38%776K | 256.28%10.98M | 97.59%-762K |
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -162.11%-59K | 1,130.37%2.63M | -382.73%-2.34M | -88.72%1.75M | -41.79%450K | 217.28%95K | 224.42%214K | 378.61%828K | 198.80%15.49M | -72.30%773K |
| Less:Other special charges | ---- | ---- | ---- | 93.23%-1M | ---- | ---- | ---- | ---- | -525.67%-14.8M | ---- |
| Less:Write off | 162.11%59K | -1,130.37%-2.63M | 382.73%2.34M | -7.50%-745K | 41.79%-450K | -217.28%-95K | -224.42%-214K | -378.61%-828K | 75.42%-693K | -81.46%-773K |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 105.08%2.82M | 28.15%-22.74M | -87.66%8.11M | 367.60%74.96M | 81.29%96.45M | -64.28%-55.58M | -122.78%-31.64M | 298.09%65.73M | 84.31%-28.01M | 213.17%53.2M |
| Income tax | 227.60%7.42M | 827.68%7M | -81.73%4.39M | 99.85%43.71M | 139.60%24.76M | -360.55%-5.82M | -88.58%755K | 792.20%24.02M | 12,542.20%21.87M | 462.53%10.33M |
| Net income | 90.75%-4.6M | 8.20%-29.74M | -91.07%3.73M | 162.65%31.25M | 67.24%71.7M | -37.98%-49.76M | -55.63%-32.4M | 216.27%41.71M | 72.09%-49.88M | 197.08%42.87M |
| Net income continuous operations | 90.75%-4.6M | 8.20%-29.74M | -91.07%3.73M | 162.65%31.25M | 67.24%71.7M | -37.98%-49.76M | -55.63%-32.4M | 216.27%41.71M | 72.09%-49.88M | 197.08%42.87M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 90.75%-4.6M | 8.20%-29.74M | -91.07%3.73M | 162.65%31.25M | 67.24%71.7M | -37.98%-49.76M | -55.63%-32.4M | 216.27%41.71M | 72.09%-49.88M | 197.08%42.87M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 90.75%-4.6M | 8.20%-29.74M | -91.07%3.73M | 162.65%31.25M | 67.24%71.7M | -37.98%-49.76M | -55.63%-32.4M | 216.27%41.71M | 72.09%-49.88M | 197.08%42.87M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 90.82%-0.0065 | 8.24%-0.0423 | -91.06%0.0053 | 162.68%0.0445 | 67.21%0.102 | -38.01%-0.0708 | -55.74%-0.0461 | 216.27%0.0593 | 72.07%-0.071 | 197.13%0.061 |
| Diluted earnings per share | 90.82%-0.0065 | 8.24%-0.0423 | -91.06%0.0053 | 162.68%0.0445 | 67.21%0.102 | -38.01%-0.0708 | -55.74%-0.0461 | 216.27%0.0593 | 72.07%-0.071 | 197.10%0.061 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.